[go: up one dir, main page]

ES2318339T3 - Agentes formadores de poros a base de hidrogel para la construccion de estructuras biodegradables. - Google Patents

Agentes formadores de poros a base de hidrogel para la construccion de estructuras biodegradables. Download PDF

Info

Publication number
ES2318339T3
ES2318339T3 ES04782412T ES04782412T ES2318339T3 ES 2318339 T3 ES2318339 T3 ES 2318339T3 ES 04782412 T ES04782412 T ES 04782412T ES 04782412 T ES04782412 T ES 04782412T ES 2318339 T3 ES2318339 T3 ES 2318339T3
Authority
ES
Spain
Prior art keywords
composition according
hydrogel
biodegradable
poly
hydrogel microparticles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES04782412T
Other languages
English (en)
Spanish (es)
Inventor
Esmaiel Jabbari
Michael J. Yaszemski
Bradford L. Currier
Lichun Lu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mayo Foundation for Medical Education and Research
Mayo Clinic in Florida
Original Assignee
Mayo Foundation for Medical Education and Research
Mayo Clinic in Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayo Foundation for Medical Education and Research, Mayo Clinic in Florida filed Critical Mayo Foundation for Medical Education and Research
Application granted granted Critical
Publication of ES2318339T3 publication Critical patent/ES2318339T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56Porous materials, e.g. foams or sponges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/48Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with macromolecular fillers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58Materials at least partially resorbable by the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Composite Materials (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials For Medical Uses (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Polymerisation Methods In General (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Medicinal Preparation (AREA)
ES04782412T 2003-08-29 2004-08-27 Agentes formadores de poros a base de hidrogel para la construccion de estructuras biodegradables. Expired - Lifetime ES2318339T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49883203P 2003-08-29 2003-08-29
US498832P 2003-08-29

Publications (1)

Publication Number Publication Date
ES2318339T3 true ES2318339T3 (es) 2009-05-01

Family

ID=34272737

Family Applications (1)

Application Number Title Priority Date Filing Date
ES04782412T Expired - Lifetime ES2318339T3 (es) 2003-08-29 2004-08-27 Agentes formadores de poros a base de hidrogel para la construccion de estructuras biodegradables.

Country Status (9)

Country Link
US (1) US20080206308A1 (fr)
EP (1) EP1664168B1 (fr)
JP (1) JP5059406B2 (fr)
AT (1) ATE416223T1 (fr)
AU (1) AU2004268013B2 (fr)
CA (1) CA2535857A1 (fr)
DE (1) DE602004018163D1 (fr)
ES (1) ES2318339T3 (fr)
WO (1) WO2005020849A2 (fr)

Families Citing this family (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1809678B1 (fr) * 2004-11-12 2013-05-22 Mayo Foundation for Medical Education and Research Poly(caprolactone fumarate) photoreticulable
US8728463B2 (en) 2005-03-11 2014-05-20 Wake Forest University Health Science Production of tissue engineered digits and limbs
US8491457B2 (en) 2005-03-11 2013-07-23 Wake Forest University Health Services Tissue engineered blood vessels
US7531503B2 (en) 2005-03-11 2009-05-12 Wake Forest University Health Sciences Cell scaffold matrices with incorporated therapeutic agents
US20060204539A1 (en) 2005-03-11 2006-09-14 Anthony Atala Electrospun cell matrices
WO2006099334A2 (fr) 2005-03-11 2006-09-21 Wake Forest University Health Sciences Production par genie tissulaire de valvules cardiaques
WO2006102530A1 (fr) * 2005-03-23 2006-09-28 Mayo Foundation For Medical Education And Research Hydrogels d'oligo(poly (ethylene glycol) fumarate) photoreticulables pour administration de cellules et de medicaments
AU2006242487B2 (en) * 2005-04-29 2011-12-01 Mayo Foundation For Medical Education And Research Hydrophilic/hydrophobic polymer networks based on poly(caprolactone fumarate), poly(ethylene glycol fumarate), and copolymers thereof
BRPI0612602A2 (pt) * 2005-07-01 2010-11-23 Cinv Ag dispositivos médicos compreendendo um material compósito reticulado
DK2347775T3 (da) 2005-12-13 2020-07-13 Harvard College Skabeloner til celletransplantation
US8235939B2 (en) 2006-02-06 2012-08-07 Kci Licensing, Inc. System and method for purging a reduced pressure apparatus during the administration of reduced pressure treatment
US8029498B2 (en) 2006-03-14 2011-10-04 Kci Licensing Inc. System for percutaneously administering reduced pressure treatment using balloon dissection
US9456860B2 (en) 2006-03-14 2016-10-04 Kci Licensing, Inc. Bioresorbable foaming tissue dressing
DE102006033167A1 (de) 2006-07-10 2008-01-24 Gelita Ag Verwendung von Gelatine und einem Vernetzungsmittel zur Herstellung eines vernetzenden medizinischen Klebers
DE102006033168A1 (de) * 2006-07-10 2008-01-17 Gelita Ag Verwendung von Gelatine und einem Vernetzungsmittel zur Herstellung einer vernetzenden therapeutischen Zusammensetzung
WO2008112826A1 (fr) 2007-03-12 2008-09-18 Board Of Regents, The University Of Texas System Méthode et procédé pour la production de systèmes de reconnaissance et de libération multirevêtus
US8771713B2 (en) 2007-03-12 2014-07-08 Board Of Regents, The University Of Texas System Method and process for the production of multi-coated recognitive and releasing systems
US8821899B2 (en) 2007-03-12 2014-09-02 Board Of Regents, The University Of Texas System Method and process for the production of multi-coated recognitive and releasing systems
US8741316B2 (en) 2007-03-12 2014-06-03 Board Of Regents, The University Of Texas System Highly porous, recognitive polymer systems
JP5160115B2 (ja) * 2007-03-27 2013-03-13 シスメックス株式会社 精度管理用擬似組織及びそれを用いた精度管理方法並びにその製造方法
WO2009002401A2 (fr) * 2007-06-21 2008-12-31 President And Fellows Of Harvard College Échafaudages pour recueil ou élimination de cellules
US8313527B2 (en) 2007-11-05 2012-11-20 Allergan, Inc. Soft prosthesis shell texturing method
US10328133B2 (en) 2008-02-13 2019-06-25 President And Fellows Of Harvard College Continuous cell programming devices
US9370558B2 (en) 2008-02-13 2016-06-21 President And Fellows Of Harvard College Controlled delivery of TLR agonists in structural polymeric devices
US8668863B2 (en) 2008-02-26 2014-03-11 Board Of Regents, The University Of Texas System Dendritic macroporous hydrogels prepared by crystal templating
US9012399B2 (en) 2008-05-30 2015-04-21 President And Fellows Of Harvard College Controlled release of growth factors and signaling molecules for promoting angiogenesis
US8574629B2 (en) * 2008-08-01 2013-11-05 Anteis S.A. Injectable hydrogel with an enhanced remanence and with an enhanced ability to create volume
US9050184B2 (en) 2008-08-13 2015-06-09 Allergan, Inc. Dual plane breast implant
SG172008A1 (en) 2008-12-31 2011-07-28 Kci Licensing Inc Manifolds, systems, and methods for administering reduced pressure to a subcutaneous tissue site
WO2010120749A2 (fr) 2009-04-13 2010-10-21 President And Fellow Of Harvard College Exploiter la dynamique cellulaire pour manipuler des matériels
WO2010123938A2 (fr) * 2009-04-20 2010-10-28 Oregon Health & Science University Hydrogel biosensible
EP2429600B1 (fr) * 2009-05-15 2017-09-06 Nanyang Technological University Composition et procede de fabrication d'un echafaudage de genie tissulaire
WO2011014871A1 (fr) 2009-07-31 2011-02-03 President And Fellows Of Harvard College Programmation de cellules à des fins de thérapie tolérogénique
EP2523634A4 (fr) * 2010-01-15 2014-08-06 Univ Rice William M Système combiné de maintien d'espace et de régénération osseuse pour reconstruction d'importants défauts osseux
US8877822B2 (en) 2010-09-28 2014-11-04 Allergan, Inc. Porogen compositions, methods of making and uses
US9205577B2 (en) 2010-02-05 2015-12-08 Allergan, Inc. Porogen compositions, methods of making and uses
US9138309B2 (en) 2010-02-05 2015-09-22 Allergan, Inc. Porous materials, methods of making and uses
EP2542230A4 (fr) 2010-03-05 2013-08-28 Harvard College Amélioration de prise de greffe de cellule-souche de muscle squelettique par double apport de vegf et d'igf-1
US11202853B2 (en) 2010-05-11 2021-12-21 Allergan, Inc. Porogen compositions, methods of making and uses
US20110282464A1 (en) * 2010-05-12 2011-11-17 Timothy Sargeant Reactive Surgical Implants
US9693954B2 (en) 2010-06-25 2017-07-04 President And Fellows Of Harvard College Co-delivery of stimulatory and inhibitory factors to create temporally stable and spatially restricted zones
EP2590605A1 (fr) 2010-07-09 2013-05-15 Board of Regents of the University of Texas System Échafaudages biodégradables
IT1406053B1 (it) 2010-08-17 2014-02-06 Fond T Campanella C O E Scaffold tridimensionale polimerico di policaprolattone
CN107648668B (zh) * 2010-10-06 2021-06-18 哈佛学院董事会 用于基于材料的细胞疗法的可注射的成孔水凝胶
US8946194B2 (en) 2010-10-08 2015-02-03 Board Of Regents, University Of Texas System One-step processing of hydrogels for mechanically robust and chemically desired features
EP2624874A4 (fr) 2010-10-08 2014-04-02 Univ Texas Membrane de barrière antiadhésive utilisant de l'alginate et de l'acide hyaluronique pour des applications biomédicales
WO2012064697A2 (fr) 2010-11-08 2012-05-18 President And Fellows Of Harvard College Matières présentant des molécules de signalisation par notch pour réguler le comportement cellulaire
KR102302069B1 (ko) * 2010-11-10 2021-09-14 인리젠 장기 확대를 위한 주사가능 제제
US8679279B2 (en) 2010-11-16 2014-03-25 Allergan, Inc. Methods for creating foam-like texture
US20120219629A1 (en) * 2011-02-25 2012-08-30 Empire Technology Development Llc Compositions and methods for controlled delivery of compounds
US9458357B2 (en) 2011-03-02 2016-10-04 Massachusetts Institute Of Technology ph-sensitive sacrificial materials for the microfabrication of structures
US9675561B2 (en) 2011-04-28 2017-06-13 President And Fellows Of Harvard College Injectable cryogel vaccine devices and methods of use thereof
WO2012149358A1 (fr) 2011-04-28 2012-11-01 President And Fellows Of Harvard College Échafaudages tridimensionnels macroscopiques préformés injectables pour l'administration minimalement invasive
AU2012261848B2 (en) 2011-06-03 2017-06-15 President And Fellows Of Harvard College In situ antigen-generating cancer vaccine
EP3750567B1 (fr) * 2011-11-09 2025-06-25 Trustees of Tufts College Mousses de fibroïne de soie injectables
ES2762873T3 (es) 2012-03-29 2020-05-26 Translate Bio Inc Lípidos catiónicos ionizables
CN104244929B (zh) 2012-04-16 2017-04-05 哈佛学院董事会 用于调节免疫反应的介孔二氧化硅组合物
EP2900289A1 (fr) * 2012-09-28 2015-08-05 Allergan, Inc. Compositions porogènes, procédés de fabrication et utilisations
US11565027B2 (en) 2012-12-11 2023-01-31 Board Of Regents, The University Of Texas System Hydrogel membrane for adhesion prevention
CN104981259B (zh) 2012-12-11 2017-03-08 得克萨斯系统大学评议会 包含防粘连的水凝胶膜的试剂盒
CA2895083A1 (fr) 2012-12-13 2014-06-19 Allergan, Inc. Dispositif et procede de fabrication d'un implant mammaire a surface variable
ITTO20121159A1 (it) * 2012-12-28 2014-06-29 Fond Istituto Italiano Di Tecnologia Procedimento per la produzione di spugne polimeriche
CN103495205B (zh) * 2013-09-17 2015-04-01 中国人民解放军第二军医大学 一种可注射的镶嵌含药微粒的多孔复合微球制剂及其制备方法
CN104436298B (zh) * 2013-09-17 2016-04-06 中国人民解放军第二军医大学 一种可注射的镶嵌含bmp-2微粒的plga多孔复合微球制剂及其制备方法与应用
US10092679B2 (en) 2013-10-18 2018-10-09 Wake Forest University Health Sciences Laminous vascular constructs combining cell sheet engineering and electrospinning technologies
WO2015076252A1 (fr) * 2013-11-22 2015-05-28 独立行政法人物質・材料研究機構 Film poreux adhésif tissulaire, son procédé de fabrication, et bande de film poreux adhésif tissulaire
US10682400B2 (en) 2014-04-30 2020-06-16 President And Fellows Of Harvard College Combination vaccine devices and methods of killing cancer cells
US10092392B2 (en) 2014-05-16 2018-10-09 Allergan, Inc. Textured breast implant and methods of making same
BR112017003428A2 (pt) * 2014-08-28 2017-11-28 Bioventus Llc substratos osteoindutivos aperfeiçoados e métodos para fazer os mesmos
WO2016109555A1 (fr) 2014-12-29 2016-07-07 Bioventus, Llc Systèmes et procédés pour l'apport amélioré de molécules ostéoinductrices dans la réparation osseuse
EP3250250A4 (fr) 2015-01-30 2019-05-22 President and Fellows of Harvard College Matériaux péritumoraux et intratumoraux pour traitement anticancéreux
JP7094533B2 (ja) 2015-04-10 2022-07-04 プレジデント アンド フェローズ オブ ハーバード カレッジ 免疫細胞捕捉デバイスおよびその製造および使用方法
EP3153187B1 (fr) * 2015-10-09 2018-02-14 Yeditepe Universitesi Procédé de production d'un échafaudage de tissu
EP3411475B1 (fr) 2016-02-06 2025-08-27 President and Fellows of Harvard College Régénération de la niche hématopoïétique pour reconstituer l'immunité
CN115537372A (zh) 2016-07-13 2022-12-30 哈佛学院院长等 抗原呈递细胞模拟支架及其制备和使用方法
EP3493842A4 (fr) 2016-08-02 2020-07-29 President and Fellows of Harvard College Biomatériaux pour moduler des réponses immunitaires
US10723774B2 (en) 2016-11-17 2020-07-28 University Of South Carolina Keratin-based hydrogels
US10967098B2 (en) 2017-03-01 2021-04-06 University' of South Carolina Drug conjugated nanogels in microcapsule for delayed sustained protein delivery
US11058797B2 (en) 2017-03-08 2021-07-13 University Of South Carolina Compositions and layered structures formed therewith for regeneration of articular cartilage
WO2018165327A1 (fr) 2017-03-08 2018-09-13 Alafair Biosciences, Inc. Milieu hydrogel pour le stockage et la conservation de tissu
GB201707143D0 (en) 2017-05-04 2017-06-21 Plasticell Ltd Method for producing cells
WO2020061129A1 (fr) 2018-09-19 2020-03-26 President And Fellows Of Harvard College Compositions et procédés de marquage et de modulation de cellules in vitro et in vivo
US11672767B2 (en) 2019-05-13 2023-06-13 University Of South Carolina Enzymatically cleavable self-assembled nanoparticles for morphogen delivery
CN111978588B (zh) * 2020-08-05 2022-05-03 广东省医疗器械研究所 一种大孔水凝胶及其制备方法和应用
US12167965B2 (en) * 2020-12-07 2024-12-17 The Curators Of The University Of Missouri Liquid collagen bioinks and methods to make and use collagen structures
US20240197965A1 (en) * 2021-04-09 2024-06-20 University Of Connecticut Foam biomaterial and systems, methods, and devices for making and using same
CN113817214A (zh) * 2021-08-06 2021-12-21 广东省科学院健康医学研究所 一种多孔水凝胶海绵及其制备方法和应用
JP7768473B2 (ja) * 2021-10-18 2025-11-12 デクセリアルズ株式会社 酵素含有粒子形成用組成物、酵素含有粒子、酵素分解性樹脂組成物、及び成形体

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2862045D1 (en) * 1977-07-20 1982-11-11 Ciba Geigy Ag Process for the production of hydrogels in the form of spherically shaped beads with larger diameters
US4888413A (en) * 1988-01-11 1989-12-19 Domb Abraham J Poly(propylene glycol fumarate) compositions for biomedical applications
US5514378A (en) * 1993-02-01 1996-05-07 Massachusetts Institute Of Technology Biocompatible polymer membranes and methods of preparation of three dimensional membrane structures
JP4085341B2 (ja) * 1997-03-31 2008-05-14 ザ、リージエンツ、オブ、ザ、ユニバーシティ、オブ、ミシガン 開いたポアの生分解性マトリックス
US6271278B1 (en) * 1997-05-13 2001-08-07 Purdue Research Foundation Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strength, and superabsorbent properties
CA2221195A1 (fr) * 1997-11-14 1999-05-14 Chantal E. Holy Matrice en polymere biodegradable
US6395300B1 (en) * 1999-05-27 2002-05-28 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
KR100355563B1 (ko) * 2000-06-23 2002-10-11 주식회사 바이오메드랩 비등성 혼합물을 이용한 조직공학용 생분해성의 다공성고분자 지지체 및 그의 제조방법
TWI232873B (en) * 2000-08-18 2005-05-21 Ind Tech Res Inst Process for producing porous polymer materials
JP2003103905A (ja) * 2001-09-27 2003-04-09 Mitsubishi Paper Mills Ltd インクジェット記録物の作成方法
JP4006992B2 (ja) * 2001-12-17 2007-11-14 東洋紡績株式会社 記録材料の製造方法
AU2004237774B2 (en) * 2003-05-02 2009-09-10 Surmodics, Inc. Implantable controlled release bioactive agent delivery device

Also Published As

Publication number Publication date
EP1664168A2 (fr) 2006-06-07
AU2004268013B2 (en) 2011-05-12
JP5059406B2 (ja) 2012-10-24
JP2007503881A (ja) 2007-03-01
EP1664168B1 (fr) 2008-12-03
AU2004268013A1 (en) 2005-03-10
CA2535857A1 (fr) 2005-03-10
ATE416223T1 (de) 2008-12-15
WO2005020849A2 (fr) 2005-03-10
EP1664168A4 (fr) 2006-09-13
DE602004018163D1 (de) 2009-01-15
WO2005020849A3 (fr) 2005-07-14
US20080206308A1 (en) 2008-08-28

Similar Documents

Publication Publication Date Title
ES2318339T3 (es) Agentes formadores de poros a base de hidrogel para la construccion de estructuras biodegradables.
Kretlow et al. Injectable matrices and scaffolds for drug delivery in tissue engineering
US6417247B1 (en) Polymer/ceramic composites
US5830493A (en) Bone-forming graft
US20040115240A1 (en) Composite for attaching, growing and/or repairing of living tissues and use of said composite
Yaszemski et al. In vitro degradation of a poly (propylene fumarate)-based composite material
EP2370115B1 (fr) Eponges d'hydrogel, leurs procedes de production et leurs utilisation
CN103237565B (zh) 用于基于材料的细胞疗法的可注射的成孔水凝胶
ES2225241T3 (es) Formulaciones de acido hialuronico para suministrar proteinas osteogenicas.
Jiang et al. Design of a composite biomaterial system for tissue engineering applications
US20050165128A1 (en) Responsive biomedical composites
JP2018511622A5 (fr)
EP0484387A1 (fr) Systeme biodegradable pour la regeneration du periodonte.
EP1194463A4 (fr) Poly(propylene fumarate) reticule avec du poly(ethylene glycol)
US10960106B2 (en) Tissue repair material
Li et al. Silk fibroin/methacrylated gelatine/hydroxyapatite biomimetic nanofibrous membranes for guided bone regeneration
JP4809760B2 (ja) 皺、皮膚の窪み、および瘢痕を埋めるのに使用される、セラミックをベースにした注入可能な移植材と、その製造方法
Moussi et al. Injectable macromolecule-based calcium phosphate bone substitutes
KR100810736B1 (ko) 다당류-기능화 나노입자 및 수화젤 담체를 포함하는복합체, 이를 포함하는 서방형 약물전달 제제, 뼈충진제 및이들의 제조방법
CN107982575A (zh) Ldi-pclla-peg-pclla/羟基磷灰石电纺纤维膜的制法及其产品和应用
BR112013000896B1 (pt) Material composto compreendendo pectina e fosfato de cálcio e método para sua realização
Anton et al. Types of barrier-membrane in periodontal therapy of guided tissue regeneration
Wang et al. A novel in-situ hybrid-crosslinked oxidized hyaluronic acid/Gel-MA hydrogel membrane with significantly enhanced mechanical and osteogenic properties for guided bone regeneration
Guelcher Biocompatibility of injectable materials
Stancu et al. Developments in Hydrogel‐based Scaffolds and Bioceramics for Bone Regeneration